Zhongqing Li

Dr. Zhongqing Li


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
TYTengteng Yu
Tengteng Yu
CDChenxing Du
Chenxing Du
Xiaoke MaXiaoke Ma
Xiaoke Ma
WSWeiwei Sui
Weiwei Sui
ZYZhen Yu
Zhen Yu
MHMu Hao
Mu Hao
Multiple myeloma remains incurable due to the persistence of a minor population of multiple myeloma cells that exhibit drug resistance, which leads to relapsed and/or refractory multiple myeloma. Elucidating the mechanism underlying drug resistance and developing an effective treatment are critical for clinical management of multiple myeloma. Here we showed that promoting expression of the gene for polycomb-like protein 3 (PHF19) induced multiple myeloma cell growth and multidrug resistance in vitro and in vivo. PHF19 was overexpressed in high-risk and drug-resistant primary cells from patients. High levels of PHF19 were correlated with inferior survival of patients with multiple myeloma, in the Total Therapy 2 cohort and in the Intergroup Francophone du Myeloma (IFM) cohort. Enhancing PHF19 expression levels increased Bcl-xL, Mcl-1, and HIF-1a expression in multiple myeloma cells. PHF19 also bound directly with EZH2 and promoted the phosphorylation of EZH2 through PDK1/AKT signaling. miR-15a is a small noncoding RNA that targeted the 3′UTR of PHF19. We found that downregulation of miR-15a led to high levels of PHF19 in multiple myeloma cells. These findings revealed that PHF19 served a crucial role in multiple myeloma proliferation and drug resistance and suggested that the miR-15a/PHF19/EZH2 pathway made a pivotal contribution to multiple myeloma pathogenesis, offering a promising approach to multiple myeloma treatment. Implications: Our findings identify that PHF19 mediates EZH2 phosphorylation as a mechanism of myeloma cell drug resistance, providing a rationale to explore therapeutic potential of targeting PHF19 in relapsed or refractory patients with multiple myeloma.

10 September 2014 in Mathematical Methods in the Applied Sciences
Verified
Journal Article
Open access
PDF file
ZLZhongqing Li
Zhongqing Li
WGWenjie Gao
Wenjie Gao
This paper is devoted to the study of a nonlinear parabolic p(x)‐Laplace equation with gradient term and L1 data. The authors obtain the existence of renormalized solutions via strong convergence of truncation. Copyright © 2014 John Wiley & Sons, Ltd.

28 January 2020 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
ZLZhongqing Li
Zhongqing Li
LLLanting Liu
Lanting Liu
CDChenxing Du
Chenxing Du
ZYZhen Yu
Zhen Yu
YYYuanyuan Yang
Yuanyuan Yang
MHMu Hao
Mu Hao

28 January 2015 in Applicable Analysis
Verified
Journal Article
Closed access
ZLZhongqing Li
Zhongqing Li
WGWenjie Gao
Wenjie Gao
This paper is devoted to the study of a nonlinear elliptic equation with degenerate coercivity, zero-order term and L1 datum in the setting of variable exponent Sobolev space. The authors obtain the existence of renormalized solution and entropy solution via strong convergence of truncation. They also get some a priori estimates to the solution and the generalized gradient of the solution in the Marcinkiewicz space with variable exponent.

16 October 2018 in Acta Applicandae Mathematicae
Verified
Journal Article
Closed access
PDF file
ZLZhongqing Li
Zhongqing Li

29 October 2022 in Mediterranean Journal of Mathematics
Verified
Journal Article
Closed access
PDF file
ZLZhongqing Li
Zhongqing Li